Ethical Challenges in Biomarker-Driven Drug Development-Reference-Cited by-同舟云学术

Ethical Challenges in Biomarker-Driven Drug Development

Published:2017-09-25 Issue:1 Volume:103 Page:23-25
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Hey Spencer Phillips¹²

Affiliation:

1. Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts USA

2. Harvard Center for Bioethics; Harvard Medical School; Boston Massachusetts USA

Funder

Laura and John Arnold Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference10 articles.

1. Personal medicine-the new banking crisis;Scott;Nat. Biotechnol.,2012

2. European Medicines Agency Note for Guidance on Definitions for Genomic Biomarkers, Pharmacogenetics, Genomic Data and Sample Coding 2007 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09WC500002880.pdf

3. Public health in the precision-medicine era;Bayer;N. Engl. J. Med.,2015

4. How economics can shape precision medicines;Stern;Science,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulating Laboratory Tests: What Framework Would Best Support Safety and Validity?;The Milbank Quarterly;2024-05-13

2. Deciphering the Biological Assays to Elucidate the Potential of Bioactive Molecules;2024

3. How open science can support the 3Rs and improve animal research;Research Ideas and Outcomes;2023-08-31

4. The ethical aspects of exposome research: a systematic review;Exposome;2023-01-01

5. Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment;Trends in Cancer;2021-05